Brazil has signed a deal with Indian pharmaceutical company Bharat Biotech for the purchase of 20 million doses of Covid-19 vaccine Covaxin, news agency Reuters reported. Brazil’s Health Ministry on Thursday signed a contract for delivery between March and May.
The ministry said in a statement that the deal is worth 1.6 billion reais ($290,000), with the first 8 million doses expected to arrive in March.
Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products.
